Kelli A. Rivers
Lawyers
Filters
Noile-Immune Biotech ¥3.1 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Cadeler $597 million combination with Eneti
We are advising Cadeler on the transaction
NatWest Group $1.25 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
National Grid $1.5 billion notes offering
The notes are due 2028 and 2033
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
Fiserv €800 million notes offering
The investment-grade notes are due 2031
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Honeywell €1.15 billion senior notes offering
The investment-grade notes are due 2027 and 2032
Honeywell $1.75 billion senior notes offering
The investment-grade notes are due 2029 and 2034
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing